{"transactions":[{"id":1459849,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:18:10.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The stock option was granted in consideration for consulting services that reporting person will perform for the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option shall vest in quarterly increments, based upon the services performed by the reporting person under the related Consulting Agreement."}],"balance_after":20000,"derivative":{"exercise_price":5.27,"expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-24-077836","document":"tm2417696-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077836/tm2417696-5_4seq1.xml","form_type":"4"}},{"id":1459848,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:18:10.000Z","date":"2023-11-27","kind":"grant","planned":false,"acquired":true,"shares":2146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The stock option was granted in consideration for consulting services that reporting person will perform for the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest immediately upon grant date."}],"balance_after":2146,"derivative":{"exercise_price":7.39,"expiration_date":"2033-11-27","underlying":"Common Stock","underlying_shares":2146},"source":{"system":"sec-edgar","filing":"0001104659-24-077836","document":"tm2417696-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077836/tm2417696-5_4seq1.xml","form_type":"4"}},{"id":1459847,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:18:10.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":26200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2024, stockholders of Annovis Bio, Inc. (\"the Company\") approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest immediately upon grant date."}],"balance_after":26200,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":26200},"source":{"system":"sec-edgar","filing":"0001104659-24-077836","document":"tm2417696-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077836/tm2417696-5_4seq1.xml","form_type":"4"}},{"id":1731166,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T21:27:49.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":1990,"price":6.1,"value":12139.0,"ownership":{"direct":true},"balance_after":61167,"source":{"system":"sec-edgar","filing":"0001104659-23-120769","document":"tm2331305-10_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120769/tm2331305-10_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1732547,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T19:31:38.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":6.07,"value":12140.0,"ownership":{"direct":true},"balance_after":61177,"source":{"system":"sec-edgar","filing":"0001104659-23-120303","document":"tm2331305-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120303/tm2331305-4_4seq1.xml","form_type":"4"}},{"id":1921743,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T01:14:02.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":12.61,"value":37830.0,"ownership":{"direct":true},"balance_after":59177,"source":{"system":"sec-edgar","filing":"0001104659-23-044209","document":"tm2312464-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044209/tm2312464-6_4seq1.xml","form_type":"4"}},{"id":2049600,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:40:59.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":5967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":5967,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":5967},"source":{"system":"sec-edgar","filing":"0001104659-23-005478","document":"tm234043-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005478/tm234043-4_4seq1.xml","form_type":"4"}},{"id":2443825,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:44:12.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001104659-22-001644","document":"tm221949-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001644/tm221949-6_4seq1.xml","form_type":"4"}},{"id":2543370,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-13T20:02:04.000Z","date":"2021-10-12","kind":"purchase","acquired":true,"shares":5000,"price":27.4,"value":137000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $27.25 to $27.55, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":56177,"source":{"system":"sec-edgar","filing":"0001415889-21-004863","document":"form4-10132021_011054.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000141588921004863/form4-10132021_011054.xml","form_type":"4"}},{"id":2637013,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-09T22:28:56.000Z","date":"2021-07-07","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date."}],"balance_after":4000,"derivative":{"exercise_price":102.85,"expiration_date":"2031-07-07","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-21-090746","document":"tm2121908-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921090746/tm2121908-6_4seq1.xml","form_type":"4"}},{"id":3088733,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-06T20:31:55.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":4.39,"exercise_date":"2020-07-01","expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-081243","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920081243/a4.xml","form_type":"4"}},{"id":3288587,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2020-02-05T11:02:41.000Z","date":"2020-01-31","kind":"exercise","acquired":false,"shares":3252,"price":4.8,"value":15609.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price)."},{"field":"shares","element":"transactionShares","label":"F4","text":"The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3252},"source":{"system":"sec-edgar","filing":"0001104659-20-010935","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010935/a4.xml","form_type":"4"}},{"id":3288586,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-02-05T11:02:41.000Z","date":"2020-01-31","kind":"exercise","acquired":false,"shares":48500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":34643},"source":{"system":"sec-edgar","filing":"0001104659-20-010935","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010935/a4.xml","form_type":"4"}},{"id":3288585,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2020-02-05T11:02:41.000Z","date":"2020-01-31","kind":"exercise","acquired":false,"shares":16167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11548},"source":{"system":"sec-edgar","filing":"0001104659-20-010935","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010935/a4.xml","form_type":"4"}},{"id":3288584,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T11:02:41.000Z","date":"2020-01-31","kind":"exercise","acquired":true,"shares":3252,"price":4.8,"value":15609.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price)."}],"balance_after":51177,"source":{"system":"sec-edgar","filing":"0001104659-20-010935","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010935/a4.xml","form_type":"4"}},{"id":3288583,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T11:02:41.000Z","date":"2020-01-31","kind":"exercise","acquired":true,"shares":34643,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":47925,"source":{"system":"sec-edgar","filing":"0001104659-20-010935","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010935/a4.xml","form_type":"4"}},{"id":3288582,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T11:02:41.000Z","date":"2020-01-31","kind":"exercise","acquired":true,"shares":11548,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":13282,"source":{"system":"sec-edgar","filing":"0001104659-20-010935","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010935/a4.xml","form_type":"4"}},{"id":3288581,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T11:02:41.000Z","date":"2020-01-31","kind":"purchase","acquired":true,"shares":1734,"price":6,"value":10404.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person acquired these shares in the initial public offering (\"IPO\") of Annovis Bio, Inc. (\"Annovis\")."}],"balance_after":1734,"source":{"system":"sec-edgar","filing":"0001104659-20-010935","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010935/a4.xml","form_type":"4"}}]}